The DNDi Latin America office was opened in 2004. With the primary aim to support regional R&D activities for Chagas disease, malaria, and leishmaniasis, the Latin American office also undertakes advocacy and communications activities to increase neglected diseases awareness in the region.
Projects
- ANTICOV
- Benznidazole paediatric dosage form
- Biomarkers
- Chagas Access Project
- Chagas Hit-to-lead
- Fexinidazole for Chagas
- Leishmaniasis Hit-to-lead
- New benznidazole regimens
- New cutaneous leishmaniasis combination therapies
- New visceral leishmaniasis treatments (Latin America)
Clinical trial platforms
Publications
More publications from Latin America
DNDi Latin America
Rua São Jose, 70 – Sala 601
20010-020
Centro – Rio de Janeiro
Brazil
Tel: +55 21 2529 0400